1. Search Result

Search Result

Results for "1401436-95-0" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-109198

    PI3K Cancer
    Zandelisib is a phosphatidylinositol 3-kinase (PI3K) inhibitor extracted from patent WO2019183226 A1, Compound Example 1. Zandelisib selectively inhibits p110δ with an IC50 of 3.5 nM. Zandelisib functions as an antineoplastic.